Flaxseed oil prevents trans-10, cis-12-conjugated linoleic acid-induced insulin resistance in mice

British Journal of Nutrition

Volumn 101, Issue 5, 2009, Pages 701-708

  Kelley, Darshan S ^a,b   Vemuri, Madhuri ^a,b   Adkins, Yuriko ^a,b   Gill, Sher Himmat S ^a,b   Fedor, Dawn ^a,b   Mackey, Bruce E ^c  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

Linolenic acid; Cardiovascular disease; n 3 Polyunsaturated fatty acids; Non alcoholic fatty liver disease

Indexed keywords

ADIPONECTIN; CONJUGATED LINOLEIC ACID; GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; LINOLEIC ACID; LINSEED OIL; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; FATTY LIVER; FEMALE; FOOD INTAKE; GLUCOSE HOMEOSTASIS; INSULIN RESISTANCE; LIPID COMPOSITION; LIPID LIVER LEVEL; LIVER WEIGHT; MOUSE; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PROTEIN BLOOD LEVEL;

ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DISEASE MODELS, ANIMAL; EATING; FATTY LIVER; FEMALE; INSULIN; INSULIN RESISTANCE; LINOLEIC ACIDS, CONJUGATED; LINSEED OIL; LIPID METABOLISM; LIPIDS; LIVER; MICE; MICE, INBRED C57BL; ORGAN SIZE;

ANIMALIA; MUS;

EID: 61949365751     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508027451     Document Type: Article

References (56)

1. Moller DE & Flier JS (1991) Insulin resistance - mechanisms, syndromes, and implications. N Engl J Med 325, 938-948.
2. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G & Melchionda N (1999) Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107, 450-455.
3. Smith SC Jr (2007) Multiple risk factors for cardiovascular disease and diabetes mellitus. Am J Med 120, Suppl. 1, S3-S11.
4. Li C, Ford ES, McGuire LC, Mokdad AH, Little RR & Reaven GM (2006) Trends in hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care 29, 2396-2402.
5. Adams LA & Lindor KD (2007) Nonalcoholic fatty liver disease. Ann Epidemiol 17, 863-869.
6. Zivkovic AM, German JB & Sanyal AJ (2007) Comparative review of diets for the metabolic syndrome: Implications for nonalcoholic fatty liver disease. Am J Clin Nutr 86, 285-300.
7. Vemuri M, Kelley DS, Mackey BE, Rasooly R & Bartolini G (2007) Docosahexaenoic acid (DHA) but not eicosapentaenoic acid (EPA) prevents trans-10, cis-12 conjugated linoleic acid (CLA)-induced insulin resistance in mice. Metab Syndr Relat Dis 5, 315-322.
8. Bloomgarden ZT (2005) Insulin resistance: Causes and consequences. Int Rev Neurobiol 65, 1-24.
9. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346, 1221-1231.
10. Bloomgarden ZT (2005) Concepts of insulin resistance. Metab Syndr Relat Dis 3, 284-293.
11. Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ, Febbraio MA & Watt MJ (2006) Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: Role of intramuscular accumulation of lipid metabolites. J Appl Physiol 100, 1467-1474.
12. Lovejoy JC (2002) The influence of dietary fat on insulin resistance. Curr Diab Rep 2, 435-440.
13. Petersen KF & Shulman GI (2006) Etiology of insulin resistance. Am J Med 119, S10-S16.
14. Kris-Etherton PM, Innis S & American Dietetic Association & Dietitians of Canada (2007) Position of the American Dietetic Association and Dietitians of Canada: Dietary fatty acids. J Am Diet Assoc 107 1599-1611.
15. Parodi PW (2003) Conjugated linoleic acid in food. In Advances in Conjugated Linoleic Acid Research, vol. 2, pp. 101-122 [JL Sebedio, WW Christie and R Adlof, editors]. Champaign, IL: AOCS Press.
16. Jung MY & Ha YL (1999) Conjugated linoleic acid isomers in partially hydrogenated soybean oil obtained during nonselective and selective hydrogenation processes. J Agric Food Chem 47, 704-708.
17. Kelley DS & Erickson KL (2003) Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: benefits vs. risks. Lipids 38, 377-386.
18. Tricon S, Burdge GC, Williams CM, Calder PC & Yaqoob P (2005) The effects of conjugated linoleic acid on human health-related outcomes. Proc Nutr Soc 64, 171-182.
19. Wahle KW, Heys SD & Rotondo D (2004) Conjugated linoleic acids: Are they beneficial or detrimental to health? Prog Lipid Res 43, 553-587.
20. Clement L, Poirier H, Niot I, Bocher V, Guerre-Millo M, Krief S, Staels B & Besnard P (2002) Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 43, 1400-1409.
21. Hargrave KM, Azain MJ, Kachman SD & Miner JL (2003) Conjugated linoleic acid does not improve insulin tolerance in mice. Obes Res 11 1104-1115.
22. Medina EA, Horn WF, Keim NL, Havel PJ, Benito P, Kelley DS, Nelson GJ & Erickson KL (2000) Conjugated linoleic acid supplementation in humans: effects on circulating leptin concentrations and appetite. Lipids 35, 783-788.
23. Moloney F, Yeow TP, Mullen A, Nolan JJ & Roche HM (2004) Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 80, 887-895.
24. Poirier H, Rouault C, Clement L, Niot I, Monnot MC, Guerre-Millo M & Besnard P (2005) Hyperinsulinaemia triggered by dietary conjugated linoleic acid is associated with a decrease in leptin and adiponectin plasma levels and pancreatic β cell hyperplasia in the mouse. Diabetologia 48, 1059-1065.
25. Riserus U, Vessby B, Arner P & Zethelius B (2004) Supplementation with trans10 cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: Close association with impaired insulin sensitivity. Diabetologia 47, 1016-1019.
26. Kelley DS, Bartolini GL, Warren JM, Simon VA, Mackey BE & Erickson KL (2004) Contrasting effects of t10,c12- and c9,t11-conjugated linoleic acid isomers on the fatty acid profiles of mouse liver lipids. Lipids 39, 135-141.
27. Ohashi A, Matsushita Y, Kimura K, Miyashita K & Saito M (2004) Conjugated linoleic acid deteriorates insulin resistance in obese/ diabetic mice in association with decreased production of adiponectin and leptin. J Nutr Sci Vitaminol (Tokyo) 50, 416-421.
28. Poirier H, Niot I, Clement L, Guerre-Millo M & Besnard P (2005) Development of conjugated linoleic acid (CLA)-mediated lipoatrophic syndrome in the mouse. Biochimie 87, 73-79.
29. Purushotham A, Wendel AA, Liu LF & Belury MA (2007) Maintenance of adiponectin attenuates insulin resistance induced by dietary conjugated linoleic acid in mice. J Lipid Res 48, 444-452.
30. Kelley DS, Bartolini GL, Newman JW, Vemuri M & Mackey BE (2006) Fatty acid composition of liver, adipose tissue, spleen, and heart of mice fed diets containing t10, c12-, and c9, t11-conjugated linoleic acid. Prostaglandins Leukot Essent Fatty Acids 74, 331-338.
31. El-Badry AM, Graf R & Clavien PA (2007) Omega 3 - omega 6: What is right for the liver? J Hepatol 47, 718-725.
32. Delarue J, LeFoll C, Corporeau C & Lucas D (2004) n-3 Long chain polyunsaturated fatty acids: A nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod Nutr Dev 44, 289-299.
33. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, Ruzickova J & Kopecky J (2006) Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49, 394-397.
34. Rossi AS, Lombardo YB, Lacorte JM, Chicco AG, Rouault C, Slama G & Rizkalla SW (2005) Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am J Physiol Regul Integr Comp Physiol 289, R486-R494.
35. Ide T (2005) Interaction of fish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue. Diabetes 54, 412-423.
36. Winzell MS, Pacini G & Ahren B (2006) Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice. Am J Physiol Endocrinol Metab 290, E347-E354.
37. Murase T, Aoki M & Tokimitsu I (2005) Supplementation with α-linolenic acid-rich diacylglycerol suppresses fatty liver formation accompanied by an up-regulation of β-oxidation in Zucker fatty rats. Biochim Biophys Acta 1733, 224-231.
38. Mustad VA, Demichele S, Huang YS, Mika A, Lubbers N, Berthiaume N, Polakowski J & Zinker B (2006) Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse. Metabolism 55, 1365-1374.
39. Ghafoorunissa, Ibrahim A, Rajkumar L & Acharya V (2005) Dietary (n 3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats. J Nutr 135, 2634-2638.
40. Reeves PG, Nielsen FH & Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951.
41. Kelley DS, Warren JM, Simon VA, Bartolini G, Mackey BE & Erickson KL (2002) Similar effects of c9,t11-CLA and t10,c12-CLA on immune cell functions in mice. Lipids 37, 725-728.
42. Wallace TM, Levy JC & Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27, 1487-1495.
43. Box GEP, Hunger WG & Hunter JS (1978) Statistics for Experimenters: An Introduction to Design, Data Analysis, and Model Building. New York: Wiley.
44. SAS Institute, Inc. (2004) SAS Online Doc 9.1.3 ed. Cary, NC: SAS Institute, Inc.
45. Littell RC, Milliken GA, Stroup WW, Wolfinger RD & Schabenberger O (editors) (2006) SAS System for Mixed Models, 2nd ed. Cary, NC: SAS Institute, Inc.
46. Javadi M, Beynen AC, Hovenier R, Lankhorst A, Lemmens AG, Terpstra AH & Geelen MJ (2004) Prolonged feeding of mice with conjugated linoleic acid increases hepatic fatty acid synthesis relative to oxidation. J Nutr Biochem 15, 680-687.
47. Roche HM, Noone E, Sewter C, McBennett S, Savage D, Gibney MJ, O'Rahilly S & Vidal-Puig AJ (2002) Isomerdependent metabolic effects of conjugated linoleic acid: Insights from molecular markers sterol regulatory element-binding protein-1c and LXRa. Diabetes 51, 2037-2044.
48. Takahashi Y, Kushiro M, Shinohara K & Ide T (2003) Activity and mRNA levels of enzymes involved in hepatic fatty acid synthesis and oxidation in mice fed conjugated linoleic acid. Biochim Biophys Acta 1631 265-273.
49. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim HJ, Tange T, Okuyama H, Kasai M, Ikemoto S & Ezaki O (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49, 1534-1542.
50. Yanagita T, Wang YM, Nagao K, Ujino Y & Inoue N (2005) Conjugated linoleic acid-induced fatty liver can be attenuated by combination with docosahexaenoic acid in C57BL/6N mice. J Agric Food Chem 53, 9629-9633.
51. Degrace P, Demizieux L, Gresti J, Chardigny JM, Sebedio JL & Clouet P (2003) Association of liver steatosis with lipid oversecretion and hypotriglyceridaemia in C57BL/6J mice fed trans-10, cis 12-linoleic acid. FEBS Lett 546, 335-339.
52. Degrace P, Demizieux L, Gresti J, Chardigny JM, Sebedio JL & Clouet P (2004) Hepatic steatosis is not due to impaired fatty acid oxidation capacities in C57BL/6J mice fed the conjugated trans-10,cis 12-isomer of linoleic acid. J Nutr 134, 861-867.
53. Toyoshima Y, Gavrilova O, Yakar S, Jou W, Pack S, Asghar Z, Wheeler MB & LeRoith D (2005) Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology 146, 4024-4035.
54. Poirier H, Shapiro JS, Kim RJ & Lazar MA (2006) Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue. Diabetes 55 1634-1641.
55. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J & Shoelson SE (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med 11, 183-190.
56. Botolin D, Wang Y, Christian B & Jump DB (2006) Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways. J Lipid Res 47, 181-192.